Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling - Wikidata - awgldk - TriplyDB

Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling

Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling

http://www.wikidata.org/entity/Q34559028

about

Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts EGFR signaling in renal fibrosis Evidence for the involvement of epigenetics in the progression of renal fibrogenesis Epigenetics of progression of chronic kidney disease: fact or fantasy?Epigenetics in acute kidney injury Piceatannol Attenuates Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Downregulation of Histone Deacetylase 4/5 or p38-MAPK Signaling Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expression Sphingosine Kinase 2 Deficiency Attenuates Kidney Fibrosis via IFN-γ.Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines.Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.Class I HDAC activity is required for renal protection and regeneration after acute kidney injury The interferon-related developmental regulator 1 is used by human papillomavirus to suppress NFκB activation.Treatment of chronic kidney diseases with histone deacetylase inhibitors.Qualitative and Quantitative Analysis of Histone Deacetylases in Kidney Tissue Sections.Activation of Sirtuin-1 Promotes Renal Fibroblast Activation and Aggravates Renal Fibrogenesis Recent developments in epigenetics of acute and chronic kidney diseases.Regulation of STAT signaling by acetylation.Role of 5'TG3'-interacting factors (TGIFs) in Vorinostat (HDAC inhibitor)-mediated Corneal Fibrosis Inhibition.Sex difference in EGFR pathways in mouse kidney-potential impact on the immune system Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro.Genetic Considerations in Pediatric Chronic Kidney Disease.Class I histone deacetylase activity is required for proliferation of renal epithelial cells.Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis.Class I HDACs specifically regulate E-cadherin expression in human renal epithelial cells.A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury.Epigenetic alterations in acute kidney injury.Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.Emerging role of epigenetics in systemic sclerosis pathogenesis.JAK inhibition and progressive kidney disease.Transcription factors and epigenetic modulation: its therapeutic implication in chronic kidney disease.BET Proteins: An Approach to Future Therapies in Transplantation.Knockdown of elF3a inhibits collagen synthesis in renal fibroblasts via Inhibition of transforming growth factor-β1/Smad signaling pathway The epidermal growth factor receptor pathway in chronic kidney diseases.A perspective on chronic kidney disease progression.Epigenetics of kidney disease.Role of Epigenetic Histone Modifications in Diabetic Kidney Disease Involving Renal Fibrosis.Deletion of ADP Ribosylation Factor-Like GTPase 13B Leads to Kidney Cysts.

P2860

Q26745566-987F304D-F3A5-4684-A413-9DF015DC01B9 Q26796628-F31F0781-7D4B-4295-8A95-E4A707D4D472 Q26827293-E9220DCC-4C1B-4E1E-83F5-D1E66D303FB6 Q27005788-7FD4AA28-A458-443A-9F20-4431059F96DC Q28080924-F2DA00B1-7C34-4353-B8FB-590704C08401 Q28554628-A2A80367-F27F-404A-905F-8BB6125B2D0B Q28817822-7E19F0A9-F0FE-4A74-B2B4-86ECEA359354 Q30275552-AFBBBBE1-CCA6-43C0-ADA3-013A35EF04B0 Q30275870-4626B964-53A3-44E7-9E78-3BA141A4709F Q30368366-65F0EB57-077A-4B27-AE1C-3A329F551893 Q33814199-F38FDBF2-6268-4C0E-A0B1-A58DF3A0AC52 Q33943997-9EF34BBD-4C3C-4F96-B790-AC0C27C0C593 Q33998649-C672099C-4C5E-4942-8F61-E94DD894647E Q34001310-71C0AA5A-AAEC-447B-B561-910F35FD94A4 Q35245080-D357D85A-4AF2-4A46-8DBF-7462BD721A3D Q35545347-99E8F0EA-A0D9-4BD6-9A93-61F833D725C3 Q35871084-80B543C5-E672-4C0A-9D1A-9FBF3FDE2A05 Q35897811-DE8CAE3F-24CF-4594-BD81-817B9D1EC794 Q35909055-4935A376-3098-4CFD-8D61-A0204955798D Q35998100-1E85CEDB-9E08-4407-83F3-60371A393CBF Q36000612-C5830E8B-81E7-41A4-8A1A-1EE1CFCEDC38 Q36202764-F6C4344D-47E2-4250-A2DA-768066B566B9 Q36579290-64D9A61E-6D4A-464E-B6B5-5793D103B64E Q37032679-E88D967F-7FD6-41C9-9BC5-8C708DD66681 Q37093664-A046D896-A87E-488A-B622-CE7227926CD4 Q37405334-17ADF17E-739A-4EFC-BF84-B1F377BCBABC Q37466825-3C225D92-648C-456F-8AC9-57DAA777A75C Q37629173-066AF94E-A802-4A4E-A46A-F52CD69E4078 Q38134935-7C376A57-2159-4BF2-99DA-1B79AFD45516 Q38196176-9543E244-6F39-4CA4-8C1C-A71186604C0D Q38230244-FE31F569-9825-43CF-9B8A-C405F1DEF1D9 Q38270332-610592E9-F39F-47EF-9111-CF7F3D86AABD Q38287288-E9A6A387-97E1-4116-88DE-9C72815CEE40 Q38760291-6A89437D-982D-45FE-807F-5E3B4003977D Q38828080-036A2406-9C8F-48D0-B53A-9386A422BAF2 Q38885079-51BC138B-89C1-4838-8422-29555A628CC7 Q39038570-1B7F0A09-B705-4096-81C0-CE9B1A0547B6 Q39175636-386F507B-9686-475C-9A04-A245A12BBAB5 Q39427404-79B29558-A834-413D-81C2-1B40F1E0B89E Q39787697-65B4B798-EFCC-4689-9BE7-0ABFDD133D40

P2860

Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling

http://www.wikidata.org/entity/Q34559028

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Blocking the class I histone d ...... ng TGF-beta and EGFR signaling

@ast

Blocking the class I histone d ...... ng TGF-beta and EGFR signaling

@en

Blocking the class I histone d ...... ng TGF-beta and EGFR signaling

@nl

type

label

Blocking the class I histone d ...... ng TGF-beta and EGFR signaling

@ast

Blocking the class I histone d ...... ng TGF-beta and EGFR signaling

@en

Blocking the class I histone d ...... ng TGF-beta and EGFR signaling

@nl

prefLabel

Blocking the class I histone d ...... ng TGF-beta and EGFR signaling

@ast

Blocking the class I histone d ...... ng TGF-beta and EGFR signaling

@en

Blocking the class I histone d ...... ng TGF-beta and EGFR signaling

@nl

P1433

Q34559028-D4C27097-50C0-46B0-B5E3-788CF3E3D32B

P1476

Q34559028-02A131C6-4824-4151-A9AF-8FB03411F466

P2093

Q34559028-01E8CED7-5EAC-4CBC-BB63-C8F28F597DA4

Q34559028-11ACF7D5-6C39-4DA1-ADCF-38FCEB2FCDCA

Q34559028-38C051B2-8D97-488D-9D13-DCC41A15FDBA

Q34559028-3E34D835-2196-4F7D-B6F1-1A91ECAB3090

Q34559028-50F21D59-A008-4DFA-9DDA-04869DB2158B

Q34559028-6E9E8B16-1264-4A48-9996-9443883B36AD

Q34559028-ACC63444-8A6C-4D28-9ACB-AA67096319C0

Q34559028-DAC5A2B1-F350-4268-BA9C-A76F18C0BE5D

Q34559028-FD71F08B-A618-429D-9863-589411F4DA43

P2860

Q34559028-02C17AB8-D015-42D8-AAB0-ABA4264B3C2B

Q34559028-0BE0779B-5AE2-4915-96C6-FAA5C0BBF5FE

Q34559028-103AFB9D-42BF-425B-8257-B1FEE271F275

Q34559028-1394DEB9-BC2A-4821-8885-F6D54A8FDA41

Q34559028-1706F441-093E-4622-B608-6D7D8BBA2C02

Q34559028-1991E33B-F710-4147-B5FA-30D7E94238C3

Q34559028-1AA55B4E-A579-46EA-902D-2A6B025F8206

Q34559028-1D99A419-CB9D-4CD1-A9A3-01219D34FB42

Q34559028-2057B4B9-2C8F-4BD3-BDC3-D2C8184948BD

Q34559028-23A77984-C1B4-4646-9E22-E28AECB43351

P304

Q34559028-5CAA48FF-FE07-4C86-A65B-662891021F98

P31

Q34559028-580653A9-B4A9-48E8-8643-5F0667549F20

P356

Q34559028-D6C5AA9C-91AC-4708-8CDB-FEDBDCCC4AEC

P407

Q34559028-81F8B390-BEEF-470C-8D57-244F6792F3BD

P433

Q34559028-C0910FAB-E644-46B8-9110-948F2998D6B4

P478

Q34559028-84156870-5708-4ED8-85E0-4317BB908363

P50

Q34559028-EC2790F2-42E4-458C-864D-25BB6BE411D8

P577

Q34559028-AC79B284-3B44-4D6F-89BC-A7E17AABA7B0

P5875

Q34559028-FC14AA9E-596A-4B25-9BEB-D8D959E4BC72

P698

Q34559028-5EAFB154-DB2E-4A4E-9484-C46C20135761

P932

Q34559028-93BD4BC2-7D3C-4934-A0C9-2BEBB4B4D28C

P356

JOURNAL.PONE.0054001

P1433

P1476

Blocking the class I histone d ...... ng TGF-beta and EGFR signaling

@en

P2093

Evelyn Tolbert

http://www.w3.org/2001/XMLSchema#string

George Bayliss

http://www.w3.org/2001/XMLSchema#string

Haidong Yan

http://www.w3.org/2001/XMLSchema#string

Jinhua Tang

http://www.w3.org/2001/XMLSchema#string

Li Ma

http://www.w3.org/2001/XMLSchema#string

Na Liu

http://www.w3.org/2001/XMLSchema#string

Shougang Zhuang

http://www.w3.org/2001/XMLSchema#string

Song He

http://www.w3.org/2001/XMLSchema#string

Ting C Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

Regulation of epidermal growth factor receptor trafficking by lysine deacetylase HDAC6

Acetylation-dependent signal transduction for type I interferon receptor

Cellular and molecular mechanisms of fibrosis

Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop

Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity

Histone deacetylase inhibition attenuates diabetes-associated kidney growth: potential role for epigenetic modification of the epidermal growth factor receptor

The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation.

Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs.

Histone deacetylases: unique players in shaping the epigenetic histone code.

P304

e54001

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0054001

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Murugavel Ponnusamy

P577

2013-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235364414

http://www.w3.org/2001/XMLSchema#string

P698

23342059

http://www.w3.org/2001/XMLSchema#string

P932

3546966

http://www.w3.org/2001/XMLSchema#string